Reference
Okauchi S, et al. Response to a combination of erlotinib and bevacizumab therapy after immune checkpoint inhibitor. Clinical Respiratory Journal 14: 500-501, No. 5, May 2020. Available from: URL: http://doi.org/10.1111/crj.13153
Rights and permissions
About this article
Cite this article
Afatinib/gefitinib/nivolumab. Reactions Weekly 1809, 14 (2020). https://doi.org/10.1007/s40278-020-79798-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-79798-1